AARDEX Group

AARDEX Group will be at BIO International Convention (3-6 June, 2019)

bio-international
AARDEX Group, the leader in medication adherence monitoring and management

AARDEX Group, the leader in medication adherence monitoring and management for clinical trials, will be at BIO International Convention (3-6 June, 2019).

-to discuss its experience in adherence-informed clinical trials to ensure fidelity to the research protocol
-to present its medication adherence monitoring and management ecosystem
-to share its innovative view on data-driven adherence feedback enabling digital therapeutics and patient empowerment

Come and meet us in Philadelphia (3-6 June, 2019) at the BELGIAN PAVILION, BOOTH #526

https://convention.bio.org/2019/

MEMS, medAmigo and AARDEX are AARDEX Group registered marks.

Share This Post

You may also like...

Breaking News

Clinical trial failures: Are we counting the cost of poor adherence?

Clearly it is in no one’s interests for a clinical trial to fail. Whenever these high-stake activites are abandoned and drug development pathways are aborted, missed opportunities abound. Beyond the sponsor’s missed commercial opportunity, there are missed opportunities to advance